Post-acquisition momentum stalls; volume weakness masked by cost cuts

Reported EBITDA ₹146 Cr but includes ₹18 Cr inventory impact; business EBITDA ₹128 Cr

Acquired group revenue growth 5%, legacy Sudarshan 12-13%, consolidated +5.4%

Q1 gross margin 54%, mgmt says should normalize to 50%+ YoY = current quarter margin anomalously high

After adjusting FX translation gains & raw material price inflation, analyst analysis suggests underlying volume decline

No capex needed for stated growth; only selective ROI-gated projects (backward integration, special initiatives)

Q1 ₹2,642 Cr annualized ≈ ₹10,568 Cr exceeds FY27 target band ₹9,800-10,200 Cr; mgmt: 'not revising due to geopolitical wait-and-watch' (defensive signal)

₹922 Cr → ₹531 Cr in 18 months (60% reduction vs. prior ₹800-900 Cr range two years ago)

Q1 54% gross margin will normalize to 50%+; one-off benefits acknowledged, cost-reduction driver finite

Inference may not be accurate given broad product range (€1 to €140); modest 6% growth despite geopolitical; no full value capture yet realized; business regain from lost sales is opportunity

Substantially from cost reduction or value capture

No new capex needed for volume growth; enough capacity; some selective ROI-gated projects (backward integration, special initiatives); moderate capex only

Business gross margin not that high; 2% movement QoQ from cost reduction (yields, utilities, production), minor one-offs; expect 50%+ range ongoing

Product portfolio complex (€1 to €130); focus on profitable growth that doesn't hamper gross margin; value capture continuous, major in FY27-FY28, some spillover to FY29

Accelerating acquisition debt repayment; RIECO faced labor/execution issues Q1, expecting normalization Q2+, positive by year-end; transformation to continue

Historically did double-digit consistently; business regain + value capture initiatives underpin path; FY29 guidance held since day one, not new

All price increases only to pass on cost increases; not exploiting demand-supply; will reverse pricing if raw material/oil prices soften to maintain customer trust

Quantification not possible now; will have clarity by end of Q2; numbers still fluid; no color available at this time

Results solid, minimal one-offs; given geopolitical situation, wait-and-watch approach; revisit after Q2

Guidance does not imply 15%; target high single to low double digits for acquired group

Coatings (US, Europe): subdued; Plastics: hand-to-mouth due to high polymer costs; Printing inks: volume decline long-term trend (digitalization); Specialty/Agro/Digital inks: very good growth

Categories (benzene, toluene, etc.) haven't changed; product mix shift (azo solid, high-performance & dispersion grown significantly) makes those categories more important; some specialty RMs (phosphorus-driven) now critical; specific detail to be shared offline

Yes, intercompany transfers contributed to India growth; at One Sudarshan level, not many one-offs; guidance already reflects forward margin view

Heubach made of Clariant + Heubach (~EUR 1B), lots of business lost post-integration; difficult to grow beyond market size; focus on business regain opportunity; ₹12,000+ Crores projection reflects recapture of lost sales + cost/EBITDA improvement

Reaffirmed despite Q1 annualized ₹10,568 Cr run-rate exceeding combined guidance band; implies Q2-Q4 avg ~₹8,800 Cr Qtr (vs. Q1 ₹2,642 Cr = significant slowdown

Underpinned by business regain (recovery of lost pigment sales post-acquisition dislocation) and organic growth; 16-17% CAGR guidance cited vs. 5% near-term = backloaded recovery

Q1 delivered 9.4% margin (₹128 Cr business EBITDA); guidance implies 54% decline H2—mgmt blames macro/geopolitical but won't quantify

Implies 8-12% target range; historically achieved 10%+ but post-integration recovery + cost capture path unproven; dependent on value capture realization

Mgmt acknowledges margin normalization risk; Q1 benefited from cost reduction (yields, utilities) + inventory benefit

Stated capacity headroom for stated growth (no capex for volume); selective ROI-gated projects (backward integration, special initiatives) only

Analyst structural analysis suggests volume down after FX & RM price adjustment; mgmt deflected but didn't refute; growth narrative depends on volume recovery

Mgmt flagged 50%+ normalized range, implying 2-4% margin headwind H2; value capture initiatives (cost reduction) are finite and may not continue at Q1 scale

Q1 faced energy spikes (Europe, India), logistics cycle +2 weeks, customers delaying purchases/hand-to-mouth ordering; near-term headwinds expected to continue

Post-Q1 employee restructuring agreement signed; impact not yet quantified, clarity expected by Q2 end. Project Integra (SAP consolidation) ongoing across 4 legacy systems + 130 applications

Q1 RIECO revenue ₹38 Cr (down sharply); faced execution challenges (customer delays, labor availability). Earlier plan to hive off RIECO changed to transformation; recovery path now in-house